Teva Pharmaceutical Industries Ltd. ADR 1.11% $24.97B ...

After hours: January 17 at 7:25:46 PM EST Loading Chart for GSK ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from Pfizer cleared last year.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

GlaxoSmithKline is investing in artificial intelligence (AI) with the hope of radically cutting the time and money needed to develop a drug. It has entered into an alliance with Exscientia, a new ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.40. The company’s shares closed today ...

GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including respiratory and antiviral, vaccines, over-the-counter (OTC) medicines and health-related ...

Figure 1 shows the cumulative probability of vaccination by age in days for each of the 3 DTaP vaccine doses, from NIS data. The schedule recommended by ACIP is for 3 primary doses to be ...

After hours: January 17 at 7:25:46 p.m. EST ...